Dpto. Nutrición y Bromatología II. Facultad de Farmacia. Universidad Complutense de Madrid (UCM). Pza Ramón y Cajal, s/n. E-28040 Madrid, Spain.
Curr Pharm Des. 2017;23(19):2835-2849. doi: 10.2174/1381612823666170216123219.
It is known that insufficient consumption of fiber in Western societies is directly linked to certain diseases. The required daily fiber intake can be obtained from foods such as fruits and vegetables, whole grains, legumes, nuts and others, or by eating foods enriched with fiber as a functional ingredient.
This review studies certain fiber compounds such as oligosaccharides (namely α-galactosides and fructans), arabinoxylans and β-glucans.
The European regulatory body governing nutrition and health claims aims to protect consumers' right to receive truthful information about food by verifying statements on "nutrition", "content", "health claims" and "reducing the risk of disease". Some of these foods and functional ingredients can be considered as "novel foods".
This paper describes the state of the art of certain fiber compounds and their effect on human health; the different requirements for fiber components used as functional or novel food ingredients; and the response of the European authorities to the use of this ingredient and its related health claims in terms of food labelling. After EFSA approval, these claims can be used in food labelling as an added value for consumer health, which may also improve their success in the market.
众所周知,在西方社会,膳食纤维的摄入量不足与某些疾病直接相关。膳食纤维的日推荐摄入量可以通过食用水果、蔬菜、全谷物、豆类、坚果等富含膳食纤维的食物或食用富含膳食纤维的功能性食品来获得。
本综述研究了某些膳食纤维化合物,如低聚糖(即 α-半乳糖苷和果聚糖)、阿拉伯木聚糖和 β-葡聚糖。
负责营养和健康声称监管的欧洲机构旨在通过验证有关“营养”、“含量”、“健康声称”和“降低疾病风险”的声明,保护消费者获得有关食品真实信息的权利。其中一些食品和功能性成分可以被视为“新型食品”。
本文描述了某些膳食纤维化合物及其对人体健康的影响的最新进展;用作功能性或新型食品成分的膳食纤维成分的不同要求;以及欧洲当局对这种成分及其相关健康声称在食品标签方面的使用的反应。在 EFSA 批准后,这些声称可以作为消费者健康的附加值在食品标签上使用,这也可能提高它们在市场上的成功。